Form 4: Glaukos Corp President & COO Joseph Gilliam Executes Stock Option and Sells Shares

Joseph Gilliam, President & COO of Glaukos Corp, exercised stock options and sold shares on August 21, 2024, according to a recent SEC filing.

Summary

• On August 21, 2024, Joseph Gilliam, the President & COO of Glaukos Corporation, exercised stock options to acquire 2,500 shares of common stock at a price of $55.18 per share.
• He then sold 4,420 shares at a weighted average price of $129.27 and 580 shares at a weighted average price of $130.03.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2024.
• Following these transactions, Gilliam directly owns 102,169 shares of Glaukos Corp common stock, which includes 76,419 restricted stock units and 324 shares purchased through the Employee Stock Purchase Plan.
• He also holds options to purchase 35,739 and 22,442 shares of common stock at an exercise price of $55.18.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports transactions. There is no indication of positive or negative outlook.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for executives to exercise stock options and sell shares, especially under pre-arranged trading plans like Rule 10b5-1, which allows insiders to trade without being accused of acting on non-public information.

Comparison to Industry Standards

• Insider trading activity is closely monitored in the pharmaceutical and medical device industries, similar to Glaukos, to ensure compliance with regulations.
• Companies like Alcon and Johnson & Johnson also have executives who regularly file Form 4s related to stock options and sales.
• The use of Rule 10b5-1 trading plans is a common practice among executives in publicly traded companies to avoid accusations of insider trading.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, but the transactions were executed under a pre-arranged trading plan, suggesting no significant change in the executive's long-term outlook on the company.

Key Dates